The peptide's effects on pineal gland function and melatonin secretion have implications for circadian rhythm restoration, sleep architecture improvement, and the downstream antioxidant benefits of normalized melatonin cycling
Its status as a conventional endogenous human sleep hormone remains unresolved
Subcutaneous administration suffers from: Lower bioavailability Variable absorption Different pharmacokinetics Which means the systemic exposure of DSIP via subcutaneous administration is not equivalent to what is achieved with intravenous infusion
I'm like, I'm going to be so gone on this thing
Im so happy I found you guys
Even if a vial looks clean and is labeled research grade, it may cause: Inflammation, fever, or abscess formation Systemic immune reactions Long-term unknown effects due to altered peptides or residual synthesis agents What do we tell our Patients Asking About BPC-157